Investigation of plasma homocysteine in patients with Parkinson's disease, treated with levodopa and in those treated with other medications

被引：0
|
作者：
Todorova, A. T.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
941
引用
收藏
页码：S307 / S308
页数：2
相关论文
共 50 条
  • [1] Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients
    Yuan, Rey-Yue
    Sheu, Jau-Jiuan
    Yu, Jia-Ming
    Hu, Chaur-Jong
    Tseng, Ing-Jy
    Ho, Chun-Sum
    Yeh, Ching-Ying
    Hung, Ya-Lin
    Chiang, Tsuey-Ru
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 287 (1-2) : 64 - 68
  • [2] Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients
    Valkovic, P
    Benetin, J
    Blazicek, P
    Valkovicová, L
    Gmitterová, K
    Kukumberg, P
    [J]. PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 253 - 256
  • [3] Entacapone significantly decreases elevated plasma homocysteine levels in levodopa-treated Parkinson's disease patients
    Nissinen, H
    Ellmen, J
    Vahteristo, M
    [J]. MOVEMENT DISORDERS, 2005, 20 : S94 - S94
  • [4] Plasma homocysteine levels in pergolide treated Parkinson's disease patients
    Ozkan, S
    Colak, O
    Kutlu, C
    Ertan, M
    Alatas, O
    [J]. MOVEMENT DISORDERS, 2004, 19 : S388 - S389
  • [5] Mortality in Parkinson's disease patients treated with levodopa
    Morgan, JC
    Currie, LJ
    Bennett, JP
    Harrison, MB
    Trugman, JM
    Wooten, GF
    [J]. NEUROLOGY, 2002, 58 (07) : A109 - A109
  • [6] Is the progression rate in Parkinson's disease patients treated with α-dihydroergocryptine monotherapy different from those treated with levodopa monotherapy?
    Poepperl, G
    Schwarz, J
    Linke, R
    Gasser, T
    Ruzicka, E
    Storch, A
    Tatsch, K
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05): : 119P - 119P
  • [7] Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa
    Siniscalchi, Antonio
    Gallelli, Luca
    Mercuri, Nicola B.
    Ibbadu, Guido Ferreri
    De Sarro, Giovambattista
    [J]. NUTRITIONAL NEUROSCIENCE, 2006, 9 (1-2) : 11 - 16
  • [8] Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel
    Mueller, Thomas
    Jugel, Constanze
    Ehret, Reinhard
    Ebersbach, Georg
    Bengel, Gunar
    Muhlack, Siegfried
    Klostermann, Fabian
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (09) : 1329 - 1333
  • [9] Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel
    Thomas Müller
    Constanze Jugel
    Reinhard Ehret
    Georg Ebersbach
    Gunar Bengel
    Siegfried Muhlack
    Fabian Klostermann
    [J]. Journal of Neural Transmission , 2011, 118 : 1329 - 1333
  • [10] The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: Effects of vitamin status
    Zesiewicz, Tberesa A.
    Wecker, Lynn
    Sullivan, Kelly L.
    Merlin, Lisa R.
    Hauser, Robert A.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2006, 29 (03) : 106 - 111
12345